<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Evidence Project - Mikael Svensson</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f8f9fa;
        }

        header {
            background: linear-gradient(135deg, #2c3e50 0%, #3498db 100%);
            color: white;
            padding: 2rem 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }

        nav {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
            flex-wrap: wrap;
        }

        .logo {
            font-size: 1.5rem;
            font-weight: 700;
            letter-spacing: -0.5px;
        }

        .logo a {
            color: white;
            text-decoration: none;
        }

        .nav-links {
            display: flex;
            gap: 2rem;
            list-style: none;
            flex-wrap: wrap;
        }

        .nav-links a {
            color: white;
            text-decoration: none;
            font-weight: 500;
            transition: opacity 0.3s;
            padding: 0.5rem 0;
        }

        .nav-links a:hover {
            opacity: 0.8;
            border-bottom: 2px solid white;
        }

        .container {
            max-width: 1200px;
            margin: 2rem auto;
            padding: 0 2rem;
        }

        .back-link {
            display: inline-block;
            color: #3498db;
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 500;
        }

        .back-link:hover {
            text-decoration: underline;
        }

        .project-header {
            background: white;
            padding: 3rem;
            border-radius: 10px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            margin-bottom: 2rem;
        }

        .project-header h1 {
            font-size: 2.5rem;
            color: #2c3e50;
            margin-bottom: 1rem;
        }

        .project-meta {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1.5rem;
            padding-top: 1.5rem;
            border-top: 2px solid #e0e0e0;
        }

        .meta-item {
            display: flex;
            flex-direction: column;
        }

        .meta-label {
            font-size: 0.85rem;
            color: #666;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-bottom: 0.3rem;
        }

        .meta-value {
            font-weight: 600;
            color: #2c3e50;
        }

        .section {
            background: white;
            padding: 2.5rem;
            border-radius: 10px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            margin-bottom: 2rem;
        }

        .section h2 {
            font-size: 1.8rem;
            color: #2c3e50;
            margin-bottom: 1.5rem;
            padding-bottom: 0.5rem;
            border-bottom: 3px solid #3498db;
        }

        .section p {
            color: #555;
            line-height: 1.8;
            margin-bottom: 1rem;
        }

        .publications {
            list-style: none;
        }

        .publications li {
            padding: 1.5rem;
            background: #f8f9fa;
            border-radius: 8px;
            margin-bottom: 1rem;
            transition: all 0.3s;
        }

        .publications li:hover {
            background: #e8f4f8;
            transform: translateX(5px);
        }

        .publications a {
            color: #3498db;
            text-decoration: none;
            font-weight: 600;
            font-size: 1.05rem;
            line-height: 1.5;
        }

        .publications a:hover {
            text-decoration: underline;
        }

        .media-list {
            list-style: none;
        }

        .media-list li {
            padding: 1rem;
            background: #f8f9fa;
            border-radius: 8px;
            margin-bottom: 0.8rem;
            transition: all 0.3s;
        }

        .media-list li:hover {
            background: #e8f4f8;
        }

        .media-list a {
            color: #3498db;
            text-decoration: none;
            font-weight: 500;
        }

        .media-list a:hover {
            text-decoration: underline;
        }

        .media-list .source {
            color: #999;
            font-size: 0.9rem;
            margin-left: 0.5rem;
        }

        footer {
            background: #2c3e50;
            color: white;
            text-align: center;
            padding: 2rem;
            margin-top: 4rem;
        }

        @media (max-width: 768px) {
            .project-header h1 {
                font-size: 2rem;
            }

            .project-header {
                padding: 2rem;
            }

            .section {
                padding: 1.5rem;
            }

            .nav-links {
                gap: 1rem;
                margin-top: 1rem;
            }
        }
    </style>
</head>
<body>
    <header>
        <nav>
            <div class="logo"><a href="index.html">Mikael Svensson, Ph.D.</a></div>
            <ul class="nav-links">
                <li><a href="index.html#home">Home</a></li>
                <li><a href="index.html#research">Research</a></li>
                <li><a href="index.html#projects">Projects</a></li>
                <li><a href="index.html#team">Team</a></li>
                <li><a href="publications.html">Publications</a></li>
                <li><a href="https://pharmaekonomi.substack.com/" target="_blank">Substack</a></li>
                <li><a href="index.html#teaching">Teaching</a></li>
            </ul>
        </nav>
    </header>

    <main class="container">
        <a href="index.html#projects" class="back-link">← Back to Projects</a>

        <div class="project-header">
            <h1>The Evidence-Base and Value of Cancer Drugs</h1>
            
            <div class="project-meta">
                <div class="meta-item">
                    <span class="meta-label">Period</span>
                    <span class="meta-value">2021-2024</span>
                </div>
                <div class="meta-item">
                    <span class="meta-label">Funding</span>
                    <span class="meta-value">Jan Wallander and Tom Hedelius Foundation</span>
                </div>
            </div>
        </div>

        <div class="section">
            <h2>Project Overview</h2>
            <p>
                Most newly approved cancer drugs don't have clinical data demonstrating that they make patients live longer and/or better. Instead, the approvals are increasingly based on early surrogate endpoints that are argued to predict patient-centric improvements later on. In Sweden, following the regulatory approval by EMA, an assessment (for prescription cancer drugs) is made by the Pharmaceutical Benefits Agency (TLV), which decides if the drug will be reimbursed and introduced in routine healthcare at the price set by the producer.
            </p>
            <p>
                TLV are by law mandated to consider factors such as unmet need, clinical effectiveness, and cost-effectiveness. In this project, we evaluate the clinical and cost-effectiveness data used to make such reimbursement decisions and how they relate to the price and subsequent cost to the healthcare system (and tax-payers). We also evaluate the quality of the underlying clinical trial data measurement and analysis and identify areas for improvement.
            </p>
        </div>

        <div class="section">
            <h2>Research Team</h2>
            <ul style="list-style: none; padding: 0;">
                <li style="padding: 1rem 0; border-bottom: 1px solid #e0e0e0;">
                    <strong style="color: #2c3e50; font-size: 1.05rem;">Mikael Svensson</strong>
                    <span style="color: #666; margin-left: 1rem;">Principal Investigator</span>
                </li>
                <li style="padding: 1rem 0; border-bottom: 1px solid #e0e0e0;">
                    <strong style="color: #2c3e50; font-size: 1.05rem;">Gabriella Chauca Strand</strong>
                    <span style="color: #666; margin-left: 1rem;">PhD Student</span>
                    <span style="color: #999; margin-left: 0.5rem;">•</span>
                    <a href="https://www.gu.se/en/about/find-staff/gabriellachaucastrand" target="_blank" style="color: #3498db; text-decoration: none; margin-left: 0.5rem;">University of Gothenburg</a>
                </li>
                <li style="padding: 1rem 0; border-bottom: 1px solid #e0e0e0;">
                    <strong style="color: #2c3e50; font-size: 1.05rem;">Naimi Johansson</strong>
                    <span style="color: #666; margin-left: 1rem;">Co-Investigator</span>
                    <span style="color: #999; margin-left: 0.5rem;">•</span>
                    <a href="https://sites.google.com/view/naimijohansson/" target="_blank" style="color: #3498db; text-decoration: none; margin-left: 0.5rem;">Karolinska Institute</a>
                </li>
                <li style="padding: 1rem 0; border-bottom: 1px solid #e0e0e0;">
                    <strong style="color: #2c3e50; font-size: 1.05rem;">Niklas Jakobsson</strong>
                    <span style="color: #666; margin-left: 1rem;">Co-Investigator</span>
                    <span style="color: #999; margin-left: 0.5rem;">•</span>
                    <a href="https://niklasjakobsson.wordpress.com/" target="_blank" style="color: #3498db; text-decoration: none; margin-left: 0.5rem;">Karlstad University</a>
                </li>
                <li style="padding: 1rem 0;">
                    <strong style="color: #2c3e50; font-size: 1.05rem;">Carl Bonander</strong>
                    <span style="color: #666; margin-left: 1rem;">Co-Investigator</span>
                    <span style="color: #999; margin-left: 0.5rem;">•</span>
                    <a href="https://www.gu.se/en/about/find-staff/carlbonander" target="_blank" style="color: #3498db; text-decoration: none; margin-left: 0.5rem;">University of Gothenburg</a>
                </li>
            </ul>
        </div>

        <div class="section">
            <h2>Journal Publications</h2>
            <ul class="publications">
                <li>
                    <a href="https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12045-8" target="_blank">
                        Analyses of Quality of Life in Cancer Drug Trials - A Review of Measurements and Analytical Choices in Post-Reimbursement Studies
                    </a>
                    <p style="color: #666; font-size: 0.9rem; margin-top: 0.5rem; margin-bottom: 0;">
                        Mikael Svensson, Gabriella Chauca Strand, Carl Bonander, Naimi Johansson and Niklas Jakobsson<br>
                        <em>BMC Cancer, 2024, 24: 311</em>
                    </p>
                </li>
                <li>
                    <a href="https://www.sciencedirect.com/science/article/pii/S2059702922001983" target="_blank">
                        Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
                    </a>
                    <p style="color: #666; font-size: 0.9rem; margin-top: 0.5rem; margin-bottom: 0;">
                        Gabriella Chauca Strand, Carl Bonander, Niklas Jakobsson, Naimi Johansson and Mikael Svensson<br>
                        <em>ESMO Open, 2022, 7: 100569</em>
                    </p>
                </li>
                <li>
                    <a href="https://link.springer.com/article/10.1007/s40261-023-01285-4" target="_blank">
                        Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?
                    </a>
                    <p style="color: #666; font-size: 0.9rem; margin-top: 0.5rem; margin-bottom: 0;">
                        Gabriella Chauca Strand, Naimi Johansson, Niklas Jakobsson, Carl Bonander and Mikael Svensson<br>
                        <em>Clinical Drug Investigation, 2023, 43: 621-633</em>
                    </p>
                </li>
            </ul>
        </div>

        <div class="section">
            <h2>Reports</h2>
            <ul class="publications">
                <li>
                    <a href="https://www.sns.se/artiklar/halsoekonom-overtro-pa-nya-mojligheter-inom-varden-kan-skada-folkhalsan/" target="_blank">
                        Höga kostnader och låg patientnytta ‒ att värdera insatser i hälso- och sjukvård
                    </a>
                    <p style="color: #666; font-size: 0.9rem; margin-top: 0.5rem; margin-bottom: 0;">
                        <em>SNS Report, 2022</em>
                    </p>
                </li>
            </ul>
        </div>

        <div class="section">
            <h2>Selected Presentations</h2>
            <ul style="margin-left: 1.5rem; color: #555; line-height: 2;">
                <li><strong>Division of Oncology, Sahlgrenska University Hospital</strong> (2023-12-08): Evidens för effekt och kostnadseffektivitet av nya cancerläkemedel - utmaningar från ett hälsoekonomiskt perspektiv</li>
                <li><strong>ISPOR, Boston</strong> (2023-05-08): Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data</li>
                <li><strong>SHEA, Stockholm</strong> (2023-04-25): (O)tillräcklig evidens kring effekt och kostnadseffektivitet av nya cancerläkemedel?</li>
                <li><strong>EuHEA, Oslo</strong> (2022-07-06): The clinical- and cost-effectiveness evidence of reimbursed cancer drugs</li>
            </ul>
        </div>

        <div class="section">
            <h2>Media Coverage (Selection)</h2>
            <ul class="media-list">
                <li>
                    <a href="https://www.svd.se/a/8JKjg1/forskare-ifragasatter-nyttan-med-nya-lakemedel" target="_blank">
                        Forskare ifrågasätter nyttan med nya läkemedel
                    </a>
                    <span class="source">• Svenska Dagbladet, 2023-08-21</span>
                </li>
                <li>
                    <a href="https://sverigesradio.se/artikel/forskaren-kravs-battre-kontroll-av-nya-cancermediciner" target="_blank">
                        Krävs bättre kontroll av nya cancermediciner
                    </a>
                    <span class="source">• Sveriges Radio, 2023-08-19</span>
                </li>
                <li>
                    <a href="https://www.svd.se/a/Rrp2WO/mikael-svensson-stora-resurser-laggs-pa-ineffektiv-vard" target="_blank">
                        Stora resurser läggs på ineffektiv vård
                    </a>
                    <span class="source">• Svenska Dagbladet, 2022-03-28</span>
                </li>
            </ul>
        </div>
    </main>

    <footer>
        <p>&copy; 2026 Mikael Svensson. All rights reserved.</p>
    </footer>
</body>
</html>
